Kalaris Therapeutics Inc (KLRS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kalaris Therapeutics Inc

    NASDAQ: KLRS · Real-Time Price · USD
    6.64
    -0.45 (-6.35%)
    At close: Oct 03, 2025, 3:59 PM
    6.77
    1.96%
    After-hours: Oct 03, 2025, 04:22 PM EDT

    Kalaris Therapeutics Inc Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q3 2024 Q4 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Sep 30, 2024 Dec 31, 2023
    Cash & Equivalents
    		 88.43M 100.97M 1.91M 3.17M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 1.19M 910K 314K n/a
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 228K 695K n/a n/a
    Total Current Assets
    		 91.65M 102.18M 2.15M 3.33M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.19M 910K 314K n/a
    Total Assets
    		 92.84M 103.09M 2.46M 3.33M
    Account Payables
    		 3.68M 2.37M 2.23M 2.36M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 9.25M n/a
    Other Current Liabilities
    		 686K 602K 1.72M 540K
    Total Current Liabilities
    		 7.65M 7.14M 13.77M 3.94M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 32.08M 32.08M 78.08M 44.41M
    Total Long-Term Liabilities
    		 32.08M 32.08M 78.08M 44.41M
    Total Liabilities
    		 39.73M 39.22M 91.84M 48.35M
    Total Debt
    		 n/a n/a 9.25M n/a
    Book Value
    		 53.12M 63.87M -89.38M -45.02M
    Book Value Per Share
    		 2.84 15.76 n/a -2.41
    Common Stock
    		 2K 2K n/a n/a
    Retained Earnings
    		 -138.11M -126.76M -94.53M -47.39M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 53.12M 63.87M -89.38M -45.02M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist